Cargando…
Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis
BACKGROUND: Attribute selection represents an important step in the development of discrete-choice experiments (DCEs), but is often poorly reported. In some situations, the number of attributes identified may exceed what one may find possible to pilot in a DCE. Hence, there is a need to gain insight...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572758/ https://www.ncbi.nlm.nih.gov/pubmed/23412964 http://dx.doi.org/10.2147/PPA.S38408 |
_version_ | 1782259352272371712 |
---|---|
author | Hiligsmann, Mickael van Durme, Caroline Geusens, Piet Dellaert, Benedict GC Dirksen, Carmen D van der Weijden, Trudy Reginster, Jean-Yves Boonen, Annelies |
author_facet | Hiligsmann, Mickael van Durme, Caroline Geusens, Piet Dellaert, Benedict GC Dirksen, Carmen D van der Weijden, Trudy Reginster, Jean-Yves Boonen, Annelies |
author_sort | Hiligsmann, Mickael |
collection | PubMed |
description | BACKGROUND: Attribute selection represents an important step in the development of discrete-choice experiments (DCEs), but is often poorly reported. In some situations, the number of attributes identified may exceed what one may find possible to pilot in a DCE. Hence, there is a need to gain insight into methods to select attributes in order to construct the final list of attributes. This study aims to test the feasibility of using the nominal group technique (NGT) to select attributes for DCEs. METHODS: Patient group discussions (4–8 participants) were convened to prioritize a list of 12 potentially important attributes for osteoporosis drug therapy. The NGT consisted of three steps: an individual ranking of the 12 attributes by importance from 1 to 12, a group discussion on each of the attributes, including a group review of the aggregate score of the initial rankings, and a second ranking task of the same attributes. RESULTS: Twenty-six osteoporotic patients participated in five NGT sessions. Most (80%) of the patients changed their ranking after the discussion. However, the average initial and final ranking did not differ markedly. In the final ranking, the most important medication attributes were effectiveness, side effects, and frequency and mode of administration. Some (15%) of the patients did not correctly rank from 1 to 12, and the order of attributes did play a role in the ranking. CONCLUSION: The NGT is feasible for selecting attributes for DCEs. Although in the context of this study, the NGT session had little impact on prioritizing attributes, this approach is rigorous, transparent, and improves the face validity of DCEs. Additional research in other contexts (different decisional problems or different diseases) is needed to determine the added value of the NGT session, to assess the optimal ranking/rating method with control of ordering effects, and to compare the attributes selected with the different approaches. |
format | Online Article Text |
id | pubmed-3572758 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2013 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-35727582013-02-14 Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis Hiligsmann, Mickael van Durme, Caroline Geusens, Piet Dellaert, Benedict GC Dirksen, Carmen D van der Weijden, Trudy Reginster, Jean-Yves Boonen, Annelies Patient Prefer Adherence Original Research BACKGROUND: Attribute selection represents an important step in the development of discrete-choice experiments (DCEs), but is often poorly reported. In some situations, the number of attributes identified may exceed what one may find possible to pilot in a DCE. Hence, there is a need to gain insight into methods to select attributes in order to construct the final list of attributes. This study aims to test the feasibility of using the nominal group technique (NGT) to select attributes for DCEs. METHODS: Patient group discussions (4–8 participants) were convened to prioritize a list of 12 potentially important attributes for osteoporosis drug therapy. The NGT consisted of three steps: an individual ranking of the 12 attributes by importance from 1 to 12, a group discussion on each of the attributes, including a group review of the aggregate score of the initial rankings, and a second ranking task of the same attributes. RESULTS: Twenty-six osteoporotic patients participated in five NGT sessions. Most (80%) of the patients changed their ranking after the discussion. However, the average initial and final ranking did not differ markedly. In the final ranking, the most important medication attributes were effectiveness, side effects, and frequency and mode of administration. Some (15%) of the patients did not correctly rank from 1 to 12, and the order of attributes did play a role in the ranking. CONCLUSION: The NGT is feasible for selecting attributes for DCEs. Although in the context of this study, the NGT session had little impact on prioritizing attributes, this approach is rigorous, transparent, and improves the face validity of DCEs. Additional research in other contexts (different decisional problems or different diseases) is needed to determine the added value of the NGT session, to assess the optimal ranking/rating method with control of ordering effects, and to compare the attributes selected with the different approaches. Dove Medical Press 2013-02-07 /pmc/articles/PMC3572758/ /pubmed/23412964 http://dx.doi.org/10.2147/PPA.S38408 Text en © 2013 Hiligsmann et al, publisher and licensee Dove Medical Press Ltd. This is an Open Access article which permits unrestricted noncommercial use, provided the original work is properly cited. |
spellingShingle | Original Research Hiligsmann, Mickael van Durme, Caroline Geusens, Piet Dellaert, Benedict GC Dirksen, Carmen D van der Weijden, Trudy Reginster, Jean-Yves Boonen, Annelies Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis |
title | Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis |
title_full | Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis |
title_fullStr | Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis |
title_full_unstemmed | Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis |
title_short | Nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis |
title_sort | nominal group technique to select attributes for discrete choice experiments: an example for drug treatment choice in osteoporosis |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572758/ https://www.ncbi.nlm.nih.gov/pubmed/23412964 http://dx.doi.org/10.2147/PPA.S38408 |
work_keys_str_mv | AT hiligsmannmickael nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis AT vandurmecaroline nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis AT geusenspiet nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis AT dellaertbenedictgc nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis AT dirksencarmend nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis AT vanderweijdentrudy nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis AT reginsterjeanyves nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis AT boonenannelies nominalgrouptechniquetoselectattributesfordiscretechoiceexperimentsanexamplefordrugtreatmentchoiceinosteoporosis |